| Financial Year |
March 31 2023 |
| Monetary Funds |
406,338,761.05 |
| Held-for-trading Financial Assets |
3,024,209.73 |
| Notes Receivable |
5,786,807.66 |
| Accounts Receivable |
368,377,913.77 |
| Advances to Suppliers |
55,290,688.39 |
| Other Receivables |
6,127,262.88 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
564,525,509.92 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
38,404,187.65 |
| Total Current Assets |
1,662,149,323.77 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
586,271,230.28 |
| Under-construction Projects |
60,822,177.31 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
321,155,863.24 |
| R&D expenses |
61,883,884.75 |
| Goodwill |
219,379,101.08 |
| Long-Term Deferred and Prepaid Expenses |
3,618,555.22 |
| Deferred Income Tax Assets |
58,384,890.01 |
| Other Non-Current Assets |
18,465,162.37 |
| Sub-Total of Non-Current Assets |
1,344,993,747.29 |
| Total Assets |
3,007,143,071.06 |
| Short-Term Loans |
353,820,741.82 |
| Trading Financial liabilities |
-- |
| Notes Payable |
346,015,553.97 |
| Accounts Payable |
262,689,315.64 |
| Accounts Received In Advance |
1,530,054.82 |
| Employee Compensation Payable |
30,009,478.73 |
| Taxes Payable |
10,499,537.30 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
8,350,794.88 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
74,703,772.47 |
| Other Current Liabilities |
6,881,118.97 |
| Sub-Total of Current Liabilities |
1,117,946,666.44 |
| Long-term Loans |
75,991,553.58 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
12,122,577.44 |
| Deferred Income Tax Liabilities |
33,297,993.92 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
167,067,597.80 |
| Total Liabilities |
1,285,014,264.24 |
| Paid-In Capital(Or Share Stock) |
566,239,133.00 |
| Capital Surplus |
824,606,969.38 |
| Surplus Reserve |
62,983,459.30 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
147,096,736.18 |
| Minority Stockholder's Interest |
118,838,576.68 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,603,290,230.14 |
| Owner's Equity（Stockholder's Equity） |
1,722,128,806.82 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,007,143,071.06 |
